BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6880566)

  • 1. Skeletal changes following growth hormone treatment in a child with combined hypopituitarism and a skeletal dysplasia.
    Horton WA; Howard CP; Grunt JA
    Acta Endocrinol (Copenh); 1983 Jul; 103(3):302-8. PubMed ID: 6880566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress report: growth hormone in skeletal dysplasia.
    Bridges NA; Brook CG
    Horm Res; 1994; 42(4-5):231-4. PubMed ID: 7868078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth increments with low dose intermittent growth hormone and fluoxymesterone in first year of therapy in hypopituitarism.
    Kirkland RT; Clayton GW
    Pediatrics; 1979 Mar; 63(3):386-8. PubMed ID: 220585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dental maturity in hypopituitarism, and dental response to substitution treatment.
    Myllärniemi S; Lenko HL; Perheentupa J
    Scand J Dent Res; 1978 Sep; 86(5):307-12. PubMed ID: 214846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxandrolone and human growth hormone. Comparison of growth-stimulating effects in short children.
    Raiti S; Trias E; Levitsky L; Grossman MS
    Am J Dis Child; 1973 Nov; 126(5):597-600. PubMed ID: 4355445
    [No Abstract]   [Full Text] [Related]  

  • 6. Linear growth in hypopituitary patients treated with hGH after age fifteen.
    Pertzelan A; Adler-Bier M; Kauli R; Josefsberg Z; Grunebaum M; Horodniceanu C; Laron Z
    Acta Paediatr Scand Suppl; 1979; 277():69-74. PubMed ID: 295569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone treatment for short stature.
    Van Vliet G; Styne DM; Kaplan SL; Grumbach MM
    N Engl J Med; 1983 Oct; 309(17):1016-22. PubMed ID: 6684729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of long-term human growth hormone therapy for short stature in children with growth hormone deficiency.
    Soyka LF; Bode HH; Crawford JD; Flynn FJ
    J Clin Endocrinol Metab; 1970 Jan; 30(1):1-14. PubMed ID: 4311615
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of cyproheptadine and human growth hormone on adrenocortical function in children with hypopituitarism.
    Kenien AG; Zeidner DL; Pang SJ; Becker DJ; Postellon DC; Gutai JP; Foley TP; Drash AL
    J Pediatr; 1978 Mar; 92(3):491-4. PubMed ID: 632998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of dose frequency of human growth hormone in treatment of organic and idiopathic hypopituitarism.
    Moore WV; Kaplan S; Raiti S
    J Pediatr; 1987 Jan; 110(1):144-8. PubMed ID: 3794876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Response to treatment with HGH (human growth hormone) in 33 patients with idiopathic hypopituitarism].
    Cacciari E; Cicognani A; Pirazzoli P; Salardi S; Tassoni P; Bernardi F; Zappulla F; Mazzanti L
    Minerva Pediatr; 1975 Nov; 27(36):1991-8. PubMed ID: 1186647
    [No Abstract]   [Full Text] [Related]  

  • 12. Relative importance of growth hormone and sex steroids for the growth at puberty of trunk length, limb length, and muscle width in growth hormone-deficient children.
    Tanner JM; Whitehouse RH; Hughes PC; Carter BS
    J Pediatr; 1976 Dec; 89(6):1000-8. PubMed ID: 993900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does hGH treatment promote adult height of hypopituitary children?
    van der Werff ten Bosch JJ; Bot A
    Neth J Med; 1988 Jun; 32(5-6):217-25. PubMed ID: 3393252
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in skeletal muscle after discontinuation of growth hormone treatment in young adults with hypopituitarism.
    Rutherford OM; Jones DA; Round JM; Preece MA
    Acta Paediatr Scand Suppl; 1989; 356():61-3; discussion 64, 73-4. PubMed ID: 2816359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of growth hormone therapy for patients with skeletal dysplasia.
    Kanazawa H; Tanaka H; Inoue M; Yamanaka Y; Namba N; Seino Y
    J Bone Miner Metab; 2003; 21(5):307-10. PubMed ID: 12928832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypopituitarism and diabetes mellitus: effect of human growth hormone.
    Kogut MD; Donnell GN; Ling SM; Frasier SD
    Pediatrics; 1968 May; 41(5):905-16. PubMed ID: 5654838
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibodies against animal growth hormones appearing in patients treated with human growth hormone: their specificities and influence on growth velocity.
    Pérez AR; Peña C; Poskus E; Paladini AC; Domené HM; Martínez AS; Heinrich JJ
    Acta Endocrinol (Copenh); 1985 Sep; 110(1):24-31. PubMed ID: 4036504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of human growth hormone on growth of patients with hypopituitarism. A combined study.
    Henneman PH
    JAMA; 1968 Sep; 205(12):828-36. PubMed ID: 4300038
    [No Abstract]   [Full Text] [Related]  

  • 19. Interrelation of the therapeutic effects of growth hormone and testosterone on growth in hypopituitarism.
    Aynsley-Green A; Zachmann M; Prader A
    J Pediatr; 1976 Dec; 89(6):992-9. PubMed ID: 993931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human placental lactogen and human growth hormone for hypopituitarism. Absence of growth potentiation.
    Schutt-Aine JC; Drash AL
    Am J Dis Child; 1972 May; 123(5):475-9. PubMed ID: 5026220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.